Publications by authors named "Erica Vander Mause"

Claim this Profile
G
Geometric parameters that affect the behavior of logic-gated CAR T cells.
Alexander C Partin, Richele Bruno, Sanam Shafaattalab, Erica Vander Mause, Aaron Winters

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restricting CAR T Cell Trafficking Expands Targetable Antigen Space.
Erin A Morales, Kenneth A Dietze, Jillian M Baker, Alexander Wang, Stephanie V Avila, Erica Vander Mause

bioRxiv· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic single amino acid affinity tuning of CD229 CAR T cells retains efficacy against multiple myeloma and eliminates on-target off-tumor toxicity.
Erica R Vander Mause, Jillian M Baker, Kenneth A Dietze, Sabarinath V Radhakrishnan, Thierry Iraguha

Sci Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p53-Bad* Fusion Gene Therapy Induces Apoptosis In Vitro and Reduces Zebrafish Tumor Burden in Hepatocellular Carcinoma.
Katherine E Redd Bowman, Lisa Ahne, Liam O'Brien, Erica R Vander Mause, Phong Lu

Mol Pharm· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ellman's reagent prevents dephosphorylation of histones during isolation of mitotic chromosomes.
James R Paulson, Erica R Vander Mause, Elizabeth Dillinger, Megan E Luedeman, Bakhtawar Usman

Chromosome Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Roadmap to affinity-tuned antibodies for enhanced chimeric antigen receptor T cell function and selectivity.
Erica R Vander Mause, Djordje Atanackovic, Carol S Lim, Tim Luetkens

Trends Biotechnol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine-induced T-cell responses against SARS-CoV-2 and its Omicron variant in patients with B cell-depleted lymphoma after CART therapy.
Djordje Atanackovic, Tim Luetkens, Destiny Omili, Thierry Iraguha, Forat Lutfi, Erica Vander Mause

Blood· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine.
Kapil K Saharia, Jennifer S Husson, Silke V Niederhaus, Thierry Iraguha, Stephanie V Avila, Erica Vander Mause

Clin Transl Immunology· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep dissection of the antiviral immune profile of patients with COVID-19.
Djordje Atanackovic, Stephanie V Avila, Forat Lutfi, Diego de Miguel-Perez, Xiaoxuan Fan, Erica Vander Mause

Commun Biol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-SARS-CoV-2 Immune Responses in Patients Receiving an Allogeneic Stem Cell or Organ Transplant.
Djordje Atanackovic, Tim Luetkens, Stephanie V Avila, Nancy M Hardy, Forat Lutfi, Erica Vander Mause

Vaccines (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide.
Sabarinath V Radhakrishnan, Tim Luetkens, Sandra D Scherer, Patricia Davis, Erica R Vander Mause

Nat Commun· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in delivery vectors for gene therapy in liver cancer.
Katherine E Redd Bowman, Phong Lu, Erica R Vander Mause, Carol S Lim

Ther Deliv· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p53-Bad: A Novel Tumor Suppressor/Proapoptotic Factor Hybrid Directed to the Mitochondria for Ovarian Cancer Gene Therapy.
Phong Lu, Katherine E Redd Bowman, Sarah M Brown, Madeline Joklik-Mcleod, Erica R Vander Mause

Mol Pharm· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitochondrially targeted p53 or DBD subdomain is superior to wild type p53 in ovarian cancer cells even with strong dominant negative mutant p53.
Phong Lu, Erica R Vander Mause, Katherine E Redd Bowman, Sarah M Brown, Lisa Ahne

J Ovarian Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis